Mon, Aug 17 06:58 PM

Freedom Broker raises Candel Therapeutics stock price target on trial progress

Investing.com•Mon, Aug 17, 2026, 05:10 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/analyst-ratings/freedom-broker-raises-candel-therapeutics-stock-price-target-on-trial-progress-93CH-4863757)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #freedom #broker #raises #candel #therapeutics #stock #price #target

More Headlines

FinanceSeeking Alpha• 13m ago

Nebius: Potential Bull Trap - AI Growth Story With Strategic Financing

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 13m ago

The Bottlenecks Of The Nuclear Fuel And Supply Chain

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 13m ago

Victory Trivalent International Small-Cap Fund Q2 2026 Commentary

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 15m ago

30-year Treasury yield tops 5.31%, the highest in 19 years

Treasury yields were higher as traders awaited the latest FOMC minutes due later this week.

FinanceSeeking Alpha• 20m ago

The Market Says AI Bubble, The Guidance Says Buy

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 22m ago

Paramount seeks $1.88 billion bond from state AGs to cover costs of WBD merger delay

Paramount agreed to delay its proposed acquisition of WBD to as late as June 2027 while the state AGs' case heads to trial.